Nanobiose is Biotechnology in France that focus on implantable medical devices business. Founded in 2016. They cover business area such as developer, a-chip, pharma, biotech, company, tool, their in vitro analysis, efficacy, drug candidate, a microfluidic biochip, line, safety, nanoparticle, nanodrug, contrast agent, implantable medical device, cosmetic, medical researcher, accurate and predictive result, early stage.
2016
( 8 years old in 2024 )
Implantable Medical Devices
-
354 Magellan Way
Alpespace Business Park
73800 Sainte-Hélène du Lac
France
Private
developera-chippharmabiotechcompanytooltheir in vitro analysisefficacydrug candidatea microfluidic biochiplinesafetynanoparticlenanodrugcontrast agentimplantable medical devicecosmeticmedical researcheraccurate and predictive resultearly stage
* We use standard office opening hours in near Nanobiose's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nanobiose is Biotechnology business from France that founded in 2016 (8 years old in 2024), Nanobiose business is focusing on Implantable Medical Devices.
Nanobiose headquarter office and corporate office address is located in 354 Magellan Way Alpespace Business Park 73800 Sainte-Hélène du Lac France.
Nanobiose was founded in France.
In 2024, Nanobiose is currently focus on implantable medical devices sector.
Above is snippet of Google Trends for "implantable medical devices" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nanobiose, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
